Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involving the inactivation of the NLRP3 inflammasome

Esculetin alleviates murine lupus nephritis by inhibiting complement activation and enhancing Nrf2 signaling pathway

(2022) Ying Zhang et al.   JOURNAL OF ETHNOPHARMACOLOGY

The roles of NLRP3 inflammasome-mediated signaling pathways in hyperuricemic nephropathy

(2021) Li Wen et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Innate immunity in diabetic kidney disease

(2020) Sydney C. W. Tang et al.   Nature Reviews Nephrology

Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy

(2020) Sandra Rayego-Mateos et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The tubular hypothesis of nephron filtration and diabetic kidney disease

(2020) Volker Vallon et al.   Nature Reviews Nephrology

The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis

(2020) Amani Abraheem Alsadiq Alyaseer et al.   Frontiers in Immunology

Trimetazidine Inhibits Renal Tubular Epithelial Cells to Mesenchymal Transition in Diabetic Rats via Upregulation of Sirt1

(2020) Yong Yang et al.   Frontiers in Pharmacology

Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches

(2020) Chetan Ram et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Recent evidence in the etiology and treatment for diabetic kidney disease

(2020) Kenichi Shikata   Journal of Diabetes Investigation

New Insights Into the Role and Mechanism of Partial Epithelial-Mesenchymal Transition in Kidney Fibrosis

(2020) Lili Sheng et al.   Frontiers in Physiology

Novel Immunomodulatory Cytokine Regulates Inflammation, Diabetes, and Obesity to Protect From Diabetic Nephropathy

(2019) Vikram Sabapathy et al.   Frontiers in Pharmacology

Berberine ameliorates renal impairment and inhibits podocyte dysfunction by targeting the PI 3K/Akt pathway in diabetic rat

(2019) Wei‐Jian Ni et al.   Journal of Diabetes Investigation

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney

(2019) Yang Gyun Kim et al.   Cells

Molecular, histological, and clinical phenotyping of diabetic nephropathy: valuable complementary information?

(2018) Paul Perco et al.   KIDNEY INTERNATIONAL

IL-6 receptor blockade ameliorates diabetic nephropathy via inhibiting inflammasome in mice

(2018) Rui Wu et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Tubulointerstitial Biomarkers for Diabetic Nephropathy

(2018) Bancha Satirapoj   Journal of Diabetes Research

Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3β Pathway

(2018) Shanshan Wang et al.   JOURNAL OF ALZHEIMERS DISEASE

Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy

(2018) Kehong Chen et al.   FASEB JOURNAL

New therapeutic agents in diabetic nephropathy

(2017) Yaeni Kim et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014

(2016) Maryam Afkarian et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy

(2016) Yuan-ye Qiu et al.   PHARMACOLOGICAL RESEARCH

Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?

(2015) Ivonne Loeffler et al.   Cells

Renal Tubulointerstitial Fibrosis in OVE26 Type 1 Diabetic Mice

(2008) David W. Powell et al.   NEPHRON EXPERIMENTAL NEPHROLOGY